NC
TNDM icon

NewSquare Capital’s Tandem Diabetes Care TNDM Stock Holding History

NewSquare Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-65
Closed -$1.59K – 884
2023
Q2 		$1.59K Hold
65
– – ﹤0.01% 549
2023
Q1 		$2.64K Hold
65
– – ﹤0.01% 541
2022
Q4 		$2.92K Buy
+65
New +$2.94K ﹤0.01% 433

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

NewSquare Capital's TNDM Position: Q3 2023 in Review

NewSquare Capital sold out of Tandem Diabetes Care (TNDM) in Q3 2023, closing a stake of 65 shares — an estimated $1.59K sold.

NewSquare Capital first reported a position in TNDM in Q4 2022 and held it in 3 quarters. The position peaked at $2.92K in Q4 2022. 226 funds tracked by Wall St. Rank hold TNDM as of Q3 2023.

  • NewSquare Capital reported no remaining Tandem Diabetes Care position as of Q3 2023 after selling out during the quarter.
  • NewSquare Capital sold 65 Tandem Diabetes Care shares in Q3 2023, an estimated $1.59K.
  • NewSquare Capital first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 3 quarters.
  • NewSquare Capital's Tandem Diabetes Care position peaked at $2.92K in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.